Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technology.
Chabannon C, Novakovitch G, Blache JL, Olivero S, Camerlo J, Genre D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: blache jl. Hematol Cell Ther. 1999 Apr;41(2):78-81. doi: 10.1007/s00282-999-0078-7. Hematol Cell Ther. 1999. PMID: 10344557
Optimization of peripheral blood stem cell collection by leukopheresis. Interaction between economic and clinical assessment of an innovation.
Le Corroller AG, Moatti JP, Chabannon C, Faucher C, Fortanier C, Ladaique P, Blache JL, Novakovitch G, Maraninchi D, Blaise D. Le Corroller AG, et al. Among authors: blache jl. Int J Technol Assess Health Care. 1999 Winter;15(1):161-72. doi: 10.1017/s0266462399152450. Int J Technol Assess Health Care. 1999. PMID: 10407603
Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.
Chabannon C, Blache JL, Sielleur I, Douville J, Faucher C, Gravis G, Arnoulet C, Oziel-Taieb S, Blaise D, Novakovitch G, Camerlo J, Chabbert I, Genre D, Appel M, Armstrong D, Maraninchi D, Viens P. Chabannon C, et al. Among authors: blache jl. Int J Oncol. 1999 Sep;15(3):511-8. doi: 10.3892/ijo.15.3.511. Int J Oncol. 1999. PMID: 10427133 Clinical Trial.
Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
Mokart D, Granata A, Crocchiolo R, Sannini A, Chow-Chine L, Brun JP, Bisbal M, Faucher M, Faucher C, Blache JL, Castagna L, Fürst S, Blaise D. Mokart D, et al. Among authors: blache jl. J Crit Care. 2015 Oct;30(5):1107-13. doi: 10.1016/j.jcrc.2015.06.020. Epub 2015 Jun 24. J Crit Care. 2015. PMID: 26193780
62 results